Tanshinone IIA Sodium Sulfonate Injection can be used intramuscularly, intravenously as well as intravenously by drip, 40～80mg/dose is recommended, and corresponding dilution is required for intravenous use. 1. Tanshinone IIA Sodium Sulfonate Injection can increase the flow of coronary artery and improve myocardial ischemia, and is suitable for the adjuvant treatment of coronary heart disease, angina pectoris and myocardial infarction. 2. The specification of the drug is often 2ml:10mg/branch, and it is generally recommended to use 40～80mg each time, when used through intramuscular injection, once a day; when used through intravenous injection, it should be diluted with 20ml of 25% dextrose injection; when used through intravenous drip, it should be diluted with 250～500ml of 5% dextrose injection or 0.9% sodium chloride injection, once a day. 3. The drug is contraindicated in people who are allergic to the product. 4. Individuals who use the drug may experience rash, maculopapular rash, dermatitis, chills, fever, pain, phlebitis, nausea, abdominal pain, hypotensive shock, anaphylactic shock and other adverse reactions. Specific use of the drug should be under the guidance of a specialist.